Zdrowie i gospodarka · 6.02.2026
FDA Announces Public Comment Period for Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics
The FDA is soliciting public comments on a proposed information collection related to the draft guidance for expedited approval of drugs and biologics for serious conditions, as required by the Paperwork Reduction Act of 1995.